CLASS III Drug recall · Reported 22 Jan 2014 · FDA Enforcement Report

Theraflu Nighttime Warming Relief Nighttime Multi-Symptom recalled

Novartis Consumer Health is recalling Theraflu Nighttime Warming Relief Nighttime Multi-Symptom Cold, Acetaminophen 325mg, distributed nationwide in the US. The recall was initiated on 15 May 2013 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesa) 08 caplets: Lot# 10121222 exp 07/13. b) 24 caplets: Lot# 10117231 exp 06/13 Lot# 10117814 exp 06/13 Lot# 10119341 exp 07/13 Lot# 10123425 exp 08/13 Lot# 10124156 exp 10/13
Quantity recalled3,768/8-caplet packages and 300,580/24-caplet packages

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-743-2014
FDA event ID
65181
Recalling firm
Novartis Consumer Health, Lincoln, NE
Classification
Class III
Status
Terminated
Recall initiated
15 May 2013
FDA classified
16 Jan 2014
Reported
22 Jan 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay
Drug class
Pain Medication

Timeline

15 May 2013Recall initiated by company
16 Jan 2014Classified by FDA+246 days
22 Jan 2014Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Theraflu Nighttime Warming Relief Nighttime Multi-Symptom Cold, Acetaminophen 325mg , Chlorpheniramine Maleate 2mg , Dextromethorphan HBr 10mg , Phenylephrine HCL 5mg, a) 8 coated caplets (NDC 0067-6437-08) b) 24 coated caplets (NDC 0067-6438-24). Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622.

Where it was distributed

Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.

Nationwide

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.

Which lots are affected?

a) 08 caplets: Lot# 10121222 exp 07/13. b) 24 caplets: Lot# 10117231 exp 06/13 Lot# 10117814 exp 06/13 Lot# 10119341 exp 07/13 Lot# 10123425 exp 08/13 Lot# 10124156 exp 10/13

Where was it sold?

Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

6 other products · FDA event 65181

More recalls from Novartis Consumer Health

All 60